ORPHA:432
Normosmic congenital hypogonadotropic hypogonadism
Also known as: Normosmic idiopathic hypogonadotropic hypogonadism · nIHH
Publications
19,061
Trials
72
Interventional, condition-specific
Researchers
1,095
Distinct authors in sample
Gene link
CCDC141, GNRH1, KLB
Strong
Readiness
5/6
Stages with a signal
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0018555
- UMLS:C0271623
- NCIT:C113347
Additional Mondo synonyms (8)
central hypogonadism · gonadotropic deficiency · hypogonadism, hypogonadotropic · hypogonadotropic hypogonadism · hypogonadotropic hypogonadism with or without anosmia · low gonadotropins (secondary hypogonadism) · normosmic congenital hypogonadotropic hypogonadism · secondary hypogonadism
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
5/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Strong — CCDC141, GNRH1, KLB, PLXNA3, SEMA3F
- LiteraturePresent
19,061 matched papers (11,419 in last 10 years) Source
- Phenotype characterisedPresent
2,425 HPO annotations (e.g. Weight loss; Increased circulating ACTH level; Adrenocortical cytomegaly) Source
- Animal modelPresent
110 genotype models (Danio rerio, Mus musculus) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
72 matched on ClinicalTrials.gov (7 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (CCDC141, GNRH1, KLB…).
GenCC classification: Strong.
Phenotypes (Monarch / HPO)
2,425
Associated phenotypes · MONDO:0018555
- Weight loss
- Increased circulating ACTH level
- Adrenocortical cytomegaly
- Fatigue
- Decreased circulating luteinizing hormone level
Showing 5 of 2425 — open Monarch for the full list.
Animal models (Monarch / Alliance)
110
Model associations linked to this Mondo ID
- TU + MO3-chd7 + MO8-chd7·ZFIN:ZDB-FISH-210115-12·Danio rerio
- TU + MO8-chd7·ZFIN:ZDB-FISH-170223-12·Danio rerio
- chd7ncu101/+ (TL)·ZFIN:ZDB-FISH-230622-2·Danio rerio
- rw0Tg + MO3-sema3e·ZFIN:ZDB-FISH-220208-2·Danio rerio
- T(7;18)50H/+ [background:] involves: 101/H * C3H/HeH·MGI:3846575·Mus musculus
- Snord116tm1Uta/Snord116+ Tg(Zp3-cre)93Knw/0 [background:] involves: C57BL/6J·MGI:3774114·Mus musculus
- T(7;18)50H/+ [background:] involves: 101/H * C3H/HeH·MGI:5497990·Mus musculus
- Kiss1rtm1Gstn/Kiss1rtm1Gstn [background:] involves: 129P2/OlaHsd·MGI:3614439·Mus musculus
- Chd7Gt(S20-7E1)Sor/Chd7+ [background:] 129S1.129S4(B6)-Chd7Gt(S20-7E1)Sor·MGI:7493591·Mus musculus
- Tbx19tm1Jdr/Tbx19tm1Jdr [background:] either: (involves: 129/Sv) or (involves: BALB/c)·MGI:2655154·Mus musculus
- Del(7Herc2-Mkrn3)13FRdni/+ [background:] involves: C57BL/6 * CD-1 * SJL·MGI:3769780·Mus musculus
- Snrpntm2Cbr/Snrpn+ [background:] involves: 129S1/Sv * C57BL/6·MGI:3618139·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
23
Drugs / clinical candidates · MONDO_0018555
- CHORIOGONADOTROPIN ALFA·phase 3
- CORIFOLLITROPIN ALFA·phase 3
- ENCLOMIPHENE CITRATE·phase 3
- FOLLITROPIN ALFA·phase 3
- GONADOTROPIN, CHORIONIC·phase 3
- LETROZOLE·phase 3
- LUTROPIN ALFA·phase 3
- MENOTROPINS·phase 3
- CLOMIPHENE·phase 2
- CLOMIPHENE CITRATE·phase 2
- FISPEMIFENE·phase 2
- GONADORELIN·phase 2
- GONADORELIN ACETATE·phase 2
- KISSPEPTIN·phase 2
- OXANDROLONE·phase 2
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
19,061
19,061 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
19,061 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
11,419 in the last 10 years · low confidence
Phrase hits: 17,407 · MeSH hits: 0
Who's working on it?
1,095
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Li Y9 papers · 2025
Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Papers in Europe PMC - 02Wang X7 papers · 2026
National Health Commission Key Laboratory of Endocrinology (Peking Union Medical College Hospital), Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Papers in Europe PMC - 03Guo Y6 papers · 2026
Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Papers in Europe PMC - 04Li H5 papers · 2025
Reproductive Medicine Department, Liaocheng People's Hospital, No. 67 Dongchang West Road, Liaocheng 252000, China.
Papers in Europe PMC - 05Li X5 papers · 2026
Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Papers in Europe PMC - 06Wang Y5 papers · 2026
Service of Endocrinology, Diabetology and Metabolism, CHUV, Lausanne, Switzerland.
Papers in Europe PMC - 07Wu X5 papers · 2026
National Health Commission Key Laboratory of Endocrinology (Peking Union Medical College Hospital), Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Papers in Europe PMC - 08Castro S4 papers · 2026
Centro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE), CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Gallo 1330, C1425EFD Buenos Aires, Argentina.
Papers in Europe PMC - 09Chen Y4 papers · 2026
Department of Endocrinology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China, cqmu.edu.cn.
Papers in Europe PMC - 10Grinspon RP4 papers · 2026
Centro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE), CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Gallo 1330, C1425EFD Buenos Aires, Argentina.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
72
interventional trials for this specific condition
72 interventional trials matched this specific condition name; 7 currently recruiting in our sample. 211 trials are registered for hypogonadism, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026 · last trial check 28 July 2026
72 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 98th percentile).
low confidence · 98th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
72 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06561594·NOT YET RECRUITING·To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection
Not reviewed·Conditions: Idiopathic Hypogonadotropic Hypogonadism·Matched via name phrase
- NCT07224438·RECRUITING·Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea
Not reviewed·Conditions: Hypothalamic Amenorrhea · Hypogonadotropic Hypogonadism·Matched via name phrase
- NCT04252001·NOT YET RECRUITING·Growing up With the Young Endocrine Support System (YESS!)
Not reviewed·Conditions: Congenital Adrenal Hyperplasia · Hypogonadotropic Hypogonadism · Growth Hormone Deficiency · Combined Pituitary Hormone Deficiency·Matched via name phrase
- NCT05896293·RECRUITING·Kisspeptin Administration Subcutaneously to Patients With IHH
Not reviewed·Conditions: Hypogonadotropic Hypogonadism·Matched via name phrase
- NCT07517952·NOT YET RECRUITING·Intratesticular Artery Resistive Index Changes After Varicocelectomy
Not reviewed·Conditions: Varicocele · Male Infertility · Secondary Hypogonadism·Matched via name phrase
- NCT05569577·RECRUITING·An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients
Not reviewed·Conditions: Luteal Phase Deficiency · Luteal Phase Support · Idiopathic Hypogonadotropic Hypogonadism·Matched via name phrase
- NCT06691815·ENROLLING BY INVITATION·Triptorelin for Early Diagnosis of Hypogonadotrophic Hypogonadism
Not reviewed·Conditions: Pubertal Delay · Hypogonadism, Hypogonadotropic · Constitutional Delay in Growth and Puberty (CDGP)·Matched via name phrase
Broader category: hypogonadism
211
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT04460872·RECRUITING·Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
Not reviewed·Conditions: Spinal Cord Injury · Spinal Cord Injuries · Trauma, Nervous System · Wounds and Injury·Matched via name phrase
- NCT06720597·RECRUITING·EndoPAT Device for Endothelial Dysfunction in ED
Not reviewed·Conditions: Erectile Dysfunction · Hypogonadism, Male · Endothelial Dysfunction·Matched via name phrase
- NCT06544473·RECRUITING·Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome
Not reviewed·Conditions: Turner Syndrome · Hypogonadism; Ovarian · Hormone Replacement Therapy · Estrogen Replacement Therapy·Matched via name phrase
- NCT06689085·RECRUITING·52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
Not reviewed·Conditions: Hypogonadism, Male·Matched via name phrase
- NCT07535905·NOT YET RECRUITING·Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer Patients
Not reviewed·Conditions: Hypogonadism · Prostate Cancer·Matched via name phrase
- NCT07687173·NOT YET RECRUITING·Assessment of Effectiveness of Pelvic Floor Muscle Training With Biofeedback in Male With Hypogonadism and Erectile Dysfunction
Not reviewed·Conditions: Erectile Disfunction · Hypogonadal Males · Functional Hypogonadism · Pelvic Floor Muscle Exercise·Matched via name phrase
- NCT07500766·NOT YET RECRUITING·Clinical Evaluation of Subcutaneous Testosterone Implants in Men With Symptomatic Hypogonadism
Not reviewed·Conditions: Male Hypogonadism · Testosterone Deficiency · Testosterone Replacement Therapy · Testosterone·Matched via name phrase
- NCT07328542·NOT YET RECRUITING·Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men
Not reviewed·Conditions: Hypogonadism, Male·Matched via name phrase
- NCT04049331·RECRUITING·Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
Not reviewed·Conditions: Hypogonadism, Male · Fatigue Syndrome, Chronic·Matched via name phrase
- NCT05249634·RECRUITING·Testosterone Treatment in Men With Chronic Kidney Disease
Not reviewed·Conditions: Hypogonadism, Male · Kidney Disease, Chronic·Matched via name phrase
- NCT07584772·NOT YET RECRUITING·Use of D-Chiro-inositol in Male Functional Hypogonadism Associated With Sexual Dysfunction
Not reviewed·Conditions: Functional Hypogonadism·Matched via name phrase
- NCT06455969·RECRUITING·Adaptions and Resiliency to Multi-Stressor OpeRations
Not reviewed·Conditions: Musculoskeletal Injury · Hypogonadism·Matched via name phrase
- NCT06570460·RECRUITING·Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome
Not reviewed·Conditions: Turner Syndrome · Hypogonadism; Ovarian · Hormone Replacement Therapy · Estrogen Replacement Therapy·Matched via name phrase
- NCT03851627·RECRUITING·Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism
Not reviewed·Conditions: Fatty Liver · Overweight/Obesity · Prediabetes/Type2 Diabetes Mellitus · Hypogonadism, Male·Matched via name phrase
- NCT04833426·RECRUITING·Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy
Not reviewed·Conditions: Prostatic Neoplasms · Hypogonadism · Testosterone Deficiency·Matched via name phrase
Observational and natural-history studies
17 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT01601171·RECRUITING·Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate
Not reviewed·Conditions: Kallmann Syndrome · Hypogonadotropic Hypogonadism · Hypothalamic Amenorrhea · Polycystic Ovarian Syndrome·Matched via name phrase
- NCT06583408·RECRUITING·The REgistry of Very Early Estrogen and AnovuLation
Not reviewed·Conditions: Hypothalamic Amenorrhea, Functional · Hypothalamic Amenorrhea · Functional Hypogonadotropic Hypogonadism·Matched via name phrase
- NCT06357442·RECRUITING·Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.
Not reviewed·Conditions: Primary Ovarian Insufficiency · Hypogonadotropic Hypogonadism · Hormone Replacement Therapy·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 3 · after dedupe 3 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 3 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (3)
- isrctn·ISRCTN12491684·Recruiting·PATHWAYS TRIAL, PATHWAYS HORIZON INTENSIVE, PATHWAYS CONNECT
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15462576·No longer recruiting·Assessment of glucose levels and insulin requirements during the menstrual cycle in women with type 1 diabetes using an automatic insulin delivery system
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN83070378·No longer recruiting·Effects of nut products on lipid metabolism in obese children
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Normosmic congenital hypogonadotropic hypogonadism — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Normosmic congenital hypogonadotropic hypogonadism" OR "Normosmic idiopathic hypogonadotropic hypogonadism" OR "central hypogonadism" OR "gonadotropic deficiency" OR "hypogonadism, hypogonadotropic" OR "hypogonadotropic hypogonadism" OR "hypogonadotropic hypogonadism with or without anosmia" OR "low gonadotropins (secondary hypogonadism)" OR "secondary hypogonadism") OR ("CCDC141" OR "CCDC141 syndrome" OR "CCDC141-related" OR "GNRH1" OR "GNRH1 syndrome" OR "GNRH1-related" OR "KLB syndrome" OR "KLB-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Normosmic congenital hypogonadotropic hypogonadism" OR "Normosmic idiopathic hypogonadotropic hypogonadism" OR "central hypogonadism" OR "gonadotropic deficiency" OR "hypogonadism, hypogonadotropic" OR "hypogonadotropic hypogonadism" OR "hypogonadotropic hypogonadism with or without anosmia" OR "low gonadotropins (secondary hypogonadism)" OR "secondary hypogonadism"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 72 interventional · 17 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"hypogonadism"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: nIHH
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- "gonadotropic deficiency" also appears on ORPHA:238666
- Publication count (19061) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-26T13:49:45.765Z
